Cancer monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cancer cells. They work by targeting specific antigens on cancer cells or immune effector cells. Several monoclonal antibodies have been developed and approved for the treatment of various cancers like lung cancer,... https://prachicmi.livepositively.com/cancer-monoclonal-antibodies-market-poised-to-reach-us-96-68-billion-by-2024/new=1